Articles in this section

• Launch of Public Health Partnership to Tackle the Silent Epidemic of Hepatitis C in Low- and Middle-Income Countries

  

  Hepatitis C PACT will work in Latin America, Asia, Africa, and Eastern Europe — collaborating with “champion countries” that are already revolutionizing hepatitis care. More

  28 July 2021

• Advocates Demand Continuous Catalytic Investment Towards Viral Hepatitis Elimination

  

  An open letter sent on behalf of 130 hepatitis and harm reduction advocates to the board and leadership of global funder, Unitaid, demands continuous investment towards HBV and HCV elimination, and to address the needs of 354 million people living with viral hepatitis worldwide. More

  16 June 2021

• Advocates Demand Migrants’ Inclusion in EU and UK COVID-19 Vaccine Plans

  

  Global advocates sent open letters to the UK and EU heads of state, and European Commission leadership urging for immediate provision of COVID-19 vaccines to all people who are migrants, refugees, displaced or non-national people residing in the UK and EU. More

  6 May 2021

• EASL Policy Statement: Drug Use and the Global Hepatitis C Elimination Goal

  

  The European Association for the Study of the Liver (EASL) made a bold policy statement, based on a science-based policy brief, to lift treatment barriers and decriminalize drug use as part of elimination strategies. More

  13 February 2021

• Harnessing the COVID-19 Response Towards Hepatitis C Elimination

  

  On February 3, 2021, Treatment Action Group, Médecins du Monde, hepCoalition, and the UNITE network convened a virtual policy dialogue among parliamentarians, global civil society organizations, and community leaders to share how COVID-19 has impacted global hepatitis C virus elimination efforts. The virtual policy dialogue offered an opportunity to reflect on the latest scientific progress and policy innovations from the International AIDS Society COVID-19 Prevention Conference. More

  1 February 2021